GOLDMAN SACHS GROUP INC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 147 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$728,000
+41.6%
157,592
+7.3%
0.00%
Q4 2018$514,000
-65.5%
146,904
-0.5%
0.00%
Q3 2018$1,488,000
+42.5%
147,626
+2.4%
0.00%
Q2 2018$1,044,000
+44.8%
144,194
+20.7%
0.00%
Q1 2018$721,000
-36.3%
119,453
+1.5%
0.00%
Q4 2017$1,132,000
-4.8%
117,676
-12.1%
0.00%
Q3 2017$1,189,000
-31.6%
133,839
-2.6%
0.00%
Q2 2017$1,738,000
-48.2%
137,453
-57.0%
0.00%
-100.0%
Q1 2017$3,357,000
+37.3%
319,468
+20.2%
0.00%0.0%
Q4 2016$2,445,000
+10.7%
265,736
+41.9%
0.00%0.0%
Q3 2016$2,208,000
-86.7%
187,260
-85.4%
0.00%
-83.3%
Q2 2016$16,604,000
+116.8%
1,283,137
+167.9%
0.01%
+200.0%
Q1 2016$7,660,000
-41.8%
479,031
+4.2%
0.00%
-50.0%
Q4 2015$13,165,000
-82.6%
459,834
-82.7%
0.00%
-84.6%
Q3 2015$75,828,000
+208.9%
2,664,346
+289.9%
0.03%
+225.0%
Q2 2015$24,544,000
+1079.4%
683,289
+1808.7%
0.01%
Q1 2015$2,081,000
-56.6%
35,798
-68.5%
0.00%
-100.0%
Q4 2014$4,798,000
-27.2%
113,791
-33.0%
0.00%0.0%
Q3 2014$6,587,000
+52.4%
169,863
+22.7%
0.00%
+100.0%
Q2 2014$4,323,000
+164.6%
138,431
+251.0%
0.00%0.0%
Q1 2014$1,634,000
+59.6%
39,441
+49.1%
0.00%
Q4 2013$1,024,00026,4460.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2015
NameSharesValueWeighting ↓
Raging Capital Management, LLC 295,790$1,367,0000.20%
Jump Trading, LLC 42,400$196,0000.06%
GAM Holding AG 83,940$388,0000.02%
Magnus Financial Group LLC 13,393$62,0000.01%
PANAGORA ASSET MANAGEMENT INC 438,606$2,026,0000.01%
Quantamental Technologies LLC 3,898$18,0000.01%
QS Investors, LLC 155,683$719,0000.01%
SFMG, LLC 11,994$55,0000.01%
Winslow, Evans & Crocker, Inc. 4,060$20,0000.01%
MILLENNIUM MANAGEMENT LLC 812,262$3,753,0000.01%
View complete list of INSYS THERAPEUTICS INC NEW shareholders